Literature DB >> 447807

Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients.

C A Gorman, N S Jiang, R D Ellefson, L R Elveback.   

Abstract

Data reported here establish that treatment regimens of 4 mg dextrothyroxine and 0.15 mg levothyroxine in hypothyroid subjects produce similar degrees of lowering of serum TSH, cholesterol, triglycerides, and phospholipid levels and equal stimulation of metabolic rate. The Murphy-Pattee total T4 determination applied to blood samples drawn 24 h after the last dose of dextrothyroxine can be used to assess adequacy of treatment. Correction of hypothyroidism requires high serum levels of dextrothyroxine than of levothyroxine. Serum T3 levels increase in patients treated with dextrothyroxine. In the treatment of hypothyroidism, the cholesterol-lowering and metabolic rate-stimulating effects of dextrothyroxine do not appear to be dissociated. Further studies are needed to determine whether such an effect can be demonstrated in euthyroid hypercholesterolemic subjects with doses established herein as equivalent in terms of the stimulating effect on metabolic rate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447807     DOI: 10.1210/jcem-49-1-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 2.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

3.  Approach to the patient with resistance to thyroid hormone and pregnancy.

Authors:  Roy E Weiss; Alexandra Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

Review 4.  Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?

Authors:  Matthew D Ettleson; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

5.  Acute and chronic effects of dextro-thyroxine on pituitary thyroid axis and on reverse triiodothyronine production in euthyroid subjects.

Authors:  B Busnardo; N Simioni; M E Girelli; T Rampazzo; A Pagnan; G Zanetti; S Dotto; N Ciuccio
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

6.  The History and Future of Treatment of Hypothyroidism.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Ann Intern Med       Date:  2016-01-05       Impact factor: 25.391

7.  Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects.

Authors:  S Yosha; M Fay; C Longcope; L E Braverman
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

8.  New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-08       Impact factor: 32.069

Review 9.  Scope and limitations of iodothyronine deiodinases in hypothyroidism.

Authors:  Balázs Gereben; Elizabeth A McAninch; Miriam O Ribeiro; Antonio C Bianco
Journal:  Nat Rev Endocrinol       Date:  2015-09-29       Impact factor: 43.330

10.  Metal Coordinated Poly-Zinc-Liothyronine Provides Stable Circulating Triiodothyronine Levels in Hypothyroid Rats.

Authors:  Rodrigo R Da Conceição; Gustavo W Fernandes; Tatiana L Fonseca; Barbara M L C Bocco; Antonio C Bianco
Journal:  Thyroid       Date:  2018-11       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.